XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total Global Payments Shareholders’ Equity
Number of Shares
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Nonredeemable Noncontrolling Interests
Total Equity
Balance at beginning of period (in shares) at Dec. 31, 2021     284,750,000          
Balance at beginning of period at Dec. 31, 2021 $ 25,869,417 $ 25,628,201   $ 22,880,261 $ 2,982,122 $ (234,182) $ 241,216  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 143,313 111,493     111,493   31,820  
Other comprehensive income (loss) (185,088) (171,787)       (171,787) (13,301)  
Stock issued under share-based compensation plans (in shares)     1,883,000          
Stock issued under share-based compensation plans 44,127 44,127   44,127        
Common stock repurchased - share-based compensation plans (in shares)     (285,000)          
Common stock repurchased - share-based compensation plans (38,423) (38,423)   (38,423)        
Share-based compensation expense $ 163,261 163,261   163,261        
Repurchase of common stock (in shares) (23,266,000)   (23,266,000)          
Repurchases of common stock $ (2,929,814) (2,929,814)   (2,841,534) (88,280)      
Distributions to noncontrolling interests (23,031)           (23,031)  
Purchase of capped calls related to issuance of convertible notes, net of taxes (229,597) (229,597)   (229,597)        
Cash dividends declared (273,955) (273,955)     (273,955)      
Balance at end of period (in shares) at Dec. 31, 2022     263,082,000          
Balance at end of period at Dec. 31, 2022 22,540,210 22,303,506   19,978,095 2,731,380 (405,969) 236,704 $ 22,540,210
Ending balance at Dec. 31, 2022 0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,028,823 986,233     986,233   41,104 1,027,337
Other comprehensive income (loss) $ 197,441 147,044       147,044 8,745 155,789
Stock issued under share-based compensation plans (in shares)     1,733,000          
Stock issued under share-based compensation plans   60,345   60,345       60,345
Common stock repurchased - share-based compensation plans (in shares)     (367,000)          
Common stock repurchased - share-based compensation plans   (41,011)   (41,011)       (41,011)
Share-based compensation expense   208,994   208,994       208,994
Share-based awards granted in connection with a business combination   2,484   2,484       2,484
Repurchase of common stock (in shares) (4,065,000)   (4,065,000)          
Repurchases of common stock $ (413,667) (413,667)   (413,667)       (413,667)
Distributions to noncontrolling interests             (26,705) (26,705)
Purchase of subsidiary shares from noncontrolling interest   5,713   5,713     20,492 26,205
Cash dividends declared   (260,431)     (260,431)     (260,431)
Balance at end of period (in shares) at Dec. 31, 2023     260,383,000          
Balance at end of period at Dec. 31, 2023 23,279,550 22,999,210   19,800,953 3,457,182 (258,925) 280,340 23,279,550
Redeemable Noncontrolling Interests                
Net income 1,486              
Other comprehensive loss 41,652              
Redeemable noncontrolling interests acquired in a business combination 471,119              
Distributions to noncontrolling interests (6,292)              
Ending balance at Dec. 31, 2023 507,965              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 323,062 313,307     313,307   7,693 321,000
Other comprehensive income (loss) $ (61,600) (38,513)       (38,513) (15,001) (53,514)
Stock issued under share-based compensation plans (in shares)     1,132,000          
Stock issued under share-based compensation plans   11,031   11,031       11,031
Common stock repurchased - share-based compensation plans (in shares)     (322,000)          
Common stock repurchased - share-based compensation plans   (42,663)   (42,663)       (42,663)
Share-based compensation expense   40,117   40,117       40,117
Repurchase of common stock (in shares) (6,061,999)   (6,062,000)          
Repurchases of common stock $ (808,400) (808,365)   (808,365)       (808,365)
Distributions to noncontrolling interests             (4,748) (4,748)
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest             358,872 358,872
Purchase of capped calls related to issuance of convertible notes, net of taxes   (194,677)   (194,677)       (194,677)
Cash dividends declared   (63,616)     (63,616)     (63,616)
Balance at end of period (in shares) at Mar. 31, 2024     255,131,000          
Balance at end of period at Mar. 31, 2024   22,215,831   18,806,396 3,706,873 (297,438) 627,245 22,843,076
Redeemable Noncontrolling Interests                
Net income 2,062              
Other comprehensive loss (8,086)              
Ending balance at Mar. 31, 2024 143,069              
Balance at beginning of period (in shares) at Dec. 31, 2023     260,383,000          
Balance at beginning of period at Dec. 31, 2023 23,279,550 22,999,210   19,800,953 3,457,182 (258,925) 280,340 23,279,550
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,644,153 1,570,365     1,570,365   51,381 1,621,746
Other comprehensive income (loss) $ (409,274) (354,806)       (354,806) (39,636) (394,442)
Stock issued under share-based compensation plans (in shares)     1,508,000          
Stock issued under share-based compensation plans   43,009   43,009       43,009
Common stock repurchased - share-based compensation plans (in shares)     (452,000)          
Common stock repurchased - share-based compensation plans   (57,092)   (57,092)       (57,092)
Share-based compensation expense   164,244   164,244       164,244
Repurchase of common stock (in shares) (12,730,000)   (12,730,000)          
Repurchases of common stock $ (1,565,688) (1,565,688)   (1,565,688)       (1,565,688)
Distributions to noncontrolling interests             (38,086) (38,086)
Contributions from noncontrolling interests             89 89
Purchase of subsidiary shares from noncontrolling interest   (71,068)   (71,807)   739 (37,702) (108,770)
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest             358,872 358,872
Purchase of capped calls related to issuance of convertible notes, net of taxes   (194,677)   (194,677)       (194,677)
Cash dividends declared   (252,811)     (252,811)     (252,811)
Balance at end of period (in shares) at Dec. 31, 2024     248,709,000          
Balance at end of period at Dec. 31, 2024 22,855,944 22,280,686   18,118,942 4,774,736 (612,992) 575,258 22,855,944
Beginning balance at Dec. 31, 2023 507,965              
Redeemable Noncontrolling Interests                
Net income 22,407              
Other comprehensive loss (14,832)              
Contributions from noncontrolling interests 3,955              
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest (358,872)              
Ending balance at Dec. 31, 2024 160,623              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 312,772 305,734     305,734   8,224 313,958
Other comprehensive income (loss) $ 206,984 163,346       163,346 36,284 199,630
Stock issued under share-based compensation plans (in shares)     1,229,000          
Stock issued under share-based compensation plans   6,340   6,340       6,340
Common stock repurchased - share-based compensation plans (in shares)     (358,000)          
Common stock repurchased - share-based compensation plans   (37,342)   (37,342)       (37,342)
Share-based compensation expense   39,740   39,740       39,740
Repurchase of common stock (in shares) (4,218,350)   (4,218,000)          
Repurchases of common stock $ (449,000) (449,037)   (449,037)       (449,037)
Distributions to noncontrolling interests             (10,327) (10,327)
Cash dividends declared   (61,124)     (61,124)     (61,124)
Balance at end of period (in shares) at Mar. 31, 2025     245,362,000          
Balance at end of period at Mar. 31, 2025 22,857,782 $ 22,248,343   $ 17,678,643 $ 5,019,346 $ (449,646) $ 609,439 $ 22,857,782
Redeemable Noncontrolling Interests                
Net income (1,186)              
Other comprehensive loss 7,354              
Ending balance at Mar. 31, 2025 $ 166,791